Adaptive Responses to PARP Inhibition Predict Response to Olaparib and Durvalumab: Multi-omic Analysis of Serial Biopsies in the AMTEC Trial
View ORCID ProfileZahi I. Mitri, View ORCID ProfileAllison L. Creason, View ORCID ProfileJayne M. Stommel, View ORCID ProfileDaniel Bottomly, View ORCID ProfileTugba Y. Ozmen, View ORCID ProfileMatthew J. Rames, View ORCID ProfileFurkan Ozmen, View ORCID ProfileBoyoung Jeong, Natalia Lukashchuk, Jack Ashton, View ORCID ProfileJeong Youn Lim, View ORCID ProfileShamilene Sivagnanam, Konjit Betra, View ORCID ProfileJinho Lee, View ORCID ProfileMarilyne Labrie, SMMART Clinical Trials Program, View ORCID ProfileLisa M. Coussens, View ORCID ProfileChristopher L. Corless, View ORCID ProfileShannon K. McWeeney, View ORCID ProfileGordon B. Mills
doi: https://doi.org/10.1101/2024.08.29.24312245
Zahi I. Mitri
1British Columbia Cancer Agency, Vancouver, BC, Canada
2Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
Allison L. Creason
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
4Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA
Jayne M. Stommel
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
Daniel Bottomly
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
Tugba Y. Ozmen
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA
Matthew J. Rames
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA
Furkan Ozmen
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA
Boyoung Jeong
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA
Natalia Lukashchuk
7Translational Medicine, Oncology Research and Development (R&D), AstraZeneca, Cambridge, United Kingdom
Jack Ashton
7Translational Medicine, Oncology Research and Development (R&D), AstraZeneca, Cambridge, United Kingdom
Jeong Youn Lim
5Biostatistics Shared Resource, Oregon Health & Science University, Portland, OR, USA
Shamilene Sivagnanam
6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA
Konjit Betra
6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA
Jinho Lee
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
8Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR, USA
Marilyne Labrie
9Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada
10Centre de Recherche du Centre Hospitalier de l’Université de Sherbrooke (CRCHUS), Sherbrooke, Canada
11Institut de Recherche sur le Cancer de l’Université de Sherbrooke (IRCUS), Sherbrooke, Canada
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
Lisa M. Coussens
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA
Christopher L. Corless
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
8Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR, USA
Shannon K. McWeeney
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
12Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, USA
Gordon B. Mills
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA
Posted August 30, 2024.
Adaptive Responses to PARP Inhibition Predict Response to Olaparib and Durvalumab: Multi-omic Analysis of Serial Biopsies in the AMTEC Trial
Zahi I. Mitri, Allison L. Creason, Jayne M. Stommel, Daniel Bottomly, Tugba Y. Ozmen, Matthew J. Rames, Furkan Ozmen, Boyoung Jeong, Natalia Lukashchuk, Jack Ashton, Jeong Youn Lim, Shamilene Sivagnanam, Konjit Betra, Jinho Lee, Marilyne Labrie, SMMART Clinical Trials Program, Lisa M. Coussens, Christopher L. Corless, Shannon K. McWeeney, Gordon B. Mills
medRxiv 2024.08.29.24312245; doi: https://doi.org/10.1101/2024.08.29.24312245
Adaptive Responses to PARP Inhibition Predict Response to Olaparib and Durvalumab: Multi-omic Analysis of Serial Biopsies in the AMTEC Trial
Zahi I. Mitri, Allison L. Creason, Jayne M. Stommel, Daniel Bottomly, Tugba Y. Ozmen, Matthew J. Rames, Furkan Ozmen, Boyoung Jeong, Natalia Lukashchuk, Jack Ashton, Jeong Youn Lim, Shamilene Sivagnanam, Konjit Betra, Jinho Lee, Marilyne Labrie, SMMART Clinical Trials Program, Lisa M. Coussens, Christopher L. Corless, Shannon K. McWeeney, Gordon B. Mills
medRxiv 2024.08.29.24312245; doi: https://doi.org/10.1101/2024.08.29.24312245
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2918)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12711)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4567)
- Geriatric Medicine (415)
- Health Economics (726)
- Health Informatics (2913)
- Health Policy (1068)
- Hematology (386)
- HIV/AIDS (922)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (467)
- Neurology (4335)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (499)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6916)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (383)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (178)